<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cancersp</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский онкологический журнал/ South Russian Journal of Cancer</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Cancer</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2686-9039</issn><publisher><publisher-name>АНО "Перспективы онкологии"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37748/2686-9039-2023-4-4-4</article-id><article-id custom-type="edn" pub-id-type="custom">HETXQY</article-id><article-id custom-type="elpub" pub-id-type="custom">cancersp-253</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Значение магнитно-резонансной томографии в диагностике и прогнозе течения раннего послеоперационного периода при хирургическом лечении больных раком поджелудочной железы</article-title><trans-title-group xml:lang="en"><trans-title>Magnetic resonance imaging relevance in diagnosis and prognosis of early postoperative period following pancreatic cancer surgical treatment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9749-709X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесников</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikov</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Колесников Евгений Николаевич – д.м.н., доцент, заведующий отделением Абдоминальной онкологии № 1, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0001-9749-709X," ext-link-type="uri">https://orcid.org/0000-0001-9749-709X,</ext-link> SPIN: 8434-6494, AuthorID: 347457, Scopus Author ID: 57190297598</p></bio><bio xml:lang="en"><p> </p><p>Evgenii N. Kolesnikov – Dr. Sci. (Med.), senior researcher, head of the department of abdominal oncology No. 1, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-8436-7250," ext-link-type="uri">https://orcid.org/0000-0001-9749-709X, </ext-link>SPIN: 8434-6494, AuthorID: 347457, Scopus Author ID: 57190297598</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5519-1113</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иозефи</surname><given-names>Д. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Iozefi</surname><given-names>D. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Иозефи Дмитрий Ярославич – заведующий отделением магнитно-резонансной томографии, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0001-5519-1113" ext-link-type="uri">https://orcid.org/0000-0001-5519-1113</ext-link>, SPIN: 9650-8237, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=799176" ext-link-type="uri">799176</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Dmitriy Ya. Iozefi – head of department of magnetic resonance imaging, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0001-5519-1113" ext-link-type="uri">https://orcid.org/0000-0001-5519-1113</ext-link>, SPIN: 9650-8237, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=799176" ext-link-type="uri">799176</ext-link></p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3061-6108</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кит</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kit</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Кит Олег Иванович – академик РАН, д.м.н., профессор, генеральный директор, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0003-3061-6108," ext-link-type="uri">https://orcid.org/0000-0003-3061-6108, </ext-link>SPIN: 1728-0329, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=343182" ext-link-type="uri">343182</ext-link>, ResearcherID: <ext-link xlink:href="https://www.webofscience.com/wos/author/record/U-2241-2017" ext-link-type="uri">U-2241-2017</ext-link>, Scopus Author ID: <ext-link xlink:href="https://www.scopus.com/authid/detail.uri?authorId=55994103100" ext-link-type="uri">55994103100</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Oleg I. Kit – Academician at the Russian Academy of Sciences, Dr. Sci. (Med.), professor, general director, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0003-3061-6108," ext-link-type="uri">https://orcid.org/0000-0003-3061-6108, </ext-link>SPIN: 1728-0329, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=343182" ext-link-type="uri">343182</ext-link>, ResearcherID: <ext-link xlink:href="https://www.webofscience.com/wos/author/record/U-2241-2017" ext-link-type="uri">U-2241-2017</ext-link>, Scopus Author ID: <ext-link xlink:href="https://www.scopus.com/authid/detail.uri?authorId=55994103100" ext-link-type="uri">55994103100</ext-link></p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1397-837X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимов</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Maksimov</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Максимов Алексей Юрьевич – д.м.н., профессор, заместитель генерального директора по перспективным научным разработкам, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-1397-837X" ext-link-type="uri">https://orcid.org/0000-0002-1397-837X</ext-link>, SPIN: 7322-5589, AuthorID: 710705, Scopus Author ID: 56579049500</p></bio><bio xml:lang="en"><p> </p><p>Aleksei Yu. Maksimov – Dr. Sci. (Med.), professor, deputy director general for advanced scientific research, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-1397-837X," ext-link-type="uri">https://orcid.org/0000-0002-1397-837X,</ext-link> SPIN: 7322-5589, AuthorID: 710705, Scopus Author ID: 56579049500</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ онкологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre for Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>04</day><month>10</month><year>2023</year></pub-date><volume>4</volume><issue>4</issue><fpage>32</fpage><lpage>43</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Колесников Е.Н., Иозефи Д.Я., Кит О.И., Максимов А.Ю., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Колесников Е.Н., Иозефи Д.Я., Кит О.И., Максимов А.Ю.</copyright-holder><copyright-holder xml:lang="en">Kolesnikov E.N., Iozefi D.Y., Kit O.I., Maksimov A.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cancersp.com/jour/article/view/253">https://www.cancersp.com/jour/article/view/253</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Совершенствование результатов прогнозирования развития панкреатической фистулы при оперативном лечении рака поджелудочной железы путем внедрения новых диагностических алгоритмов магнитно-резонансной томографии (МРТ)-оценки предполагаемой ее культи.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Проведен ретроспективный анализ результатов МРТ-исследований 1136 пациентов из базы данных медицинской информации ФГБУ «НМИЦ онкологии» Минздрава России за 2009–2020 гг. Разработана и применена оригинальная методика сканирования – транс- и кросспанкреатическая визуализация и методика МР-спектроскопии у пациентов раком поджелудочной железы. Выполнено ретроспективное сравнение предоперационных исследований: стандартный протокол МРТ без анатомического ориентирования серий; протокол МРТ с применением разработанной технологии.</p></sec><sec><title>Результаты</title><p>Результаты. Генерализованный рак поджелудочной железы был у 717 пациентов. Поражение лимфатических узлов – у 302 больных среди 419 радикально оперированных. Все случаи были подтверждены морфологически. В группе 419 пациентов, перенесших резекцию ПЖ, на основании анализа морфологических и клинических данных, а также данных предоперационного МРТ мы разработали оригинальную предоперационную шкалу оценки риска развития панкреатического свища, которую сравнили по точности с интраоперационными шкалами: шкалой риска развития панкреатической фистулы (FRS) и модифицированной FRS. Из широкого спектра метаболитов выбраны лактат и липидный комплекс. Для доказательства точности исследования мы использовали протоколы операций и результаты гистологических исследований операционного материала. Общая точность методики в возможности предсказать развитие свища – 97,5 %. Для повышения точности разработанной шкалы использовались новые визуальные предикторы (симптом «домино» и «белое на белом»), основанные на данных МРТ.</p></sec><sec><title>Заключение</title><p>Заключение. Разработанный метод использования модифицированной шкалы риска развития панкреатической фистулы позволяет уже на дооперационном этапе предсказать развитие ранних послеоперационных осложнений. При сравнении рассчитанных рисков развития панкреатической фистулы по разработанной шкале с результатами их оценки по известным шкалам (FRS и модифицированной FRS) статистический анализ показал достоверное отличие в лучшую сторону при сравнении с FRS (p = 0,0477), и тенденцию – при сравнении с модифицированной FRS (p = 0,0544).</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose of the study</title><p>Purpose of the study. Improvement of the prognostic outcomes for the pancreatic fistula development in surgical treatment for pancreatic cancer by implementation of new diagnostic algorithms for magnetic resonance imaging (MRI) assessment of supposed pancreatic stump.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. We performed a retrospective analysis of MRI results of 1136 patients from the medical data base of National Medical Research Centre for Oncology for 2009–2020. An original scanning technique, trans- and cross-pancreatic imaging and MR spectroscopy of the pancreas in patients with pancreatic cancer, was developed and applied. Preoperative examinations were compared retrospectively: a standard MRI protocol without anatomical orientation of the series; MRI protocol using the developed technology.</p></sec><sec><title>Results</title><p>Results. 717 patients were diagnosed with advanced pancreatic cancer. Lymph nodes were affected in 302 patients among 419 patients with radical surgeries. All cases were confirmed morphologically. In the group of 419 patients with pancreatic resections, based on the analysis of morphological and clinical data and preoperative MRI data, we developed an original preoperative scale for assessing the risk of pancreatic fistula development and compared its accuracy with other intraoperative scales, FRS and modified FRS. Lactate and lipid complex were selected from a wide range of metabolites. The surgical protocols and results of histological examination of the surgical material were used to prove the accuracy of the study. The overall accuracy of the technique in predicting fistula development was 97.5 %. New visual predictors («domino» and «white on white» symptoms) based on MRI data were used to improve the scale accuracy.</p></sec><sec><title>Conclusion</title><p>Conclusion. The developed method of using a modified scale for risk assessment of pancreatic fistula development allows predicting the onset of early postoperative complications already at the preoperative stage. When comparing the calculated risks of pancreatic fistula according to the developed scale with the results by the known scales (FRS and modified FRS), statistical analysis showed a significant difference for the better when compared with FRS (p = 0.0477), and a tendency when compared with modified FRS (p = 0.0544).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рак поджелудочной железы</kwd><kwd>МРТ-исследование</kwd><kwd>МРТ-оценка</kwd><kwd>опухолевая ткань</kwd><kwd>предполагаемая культя поджелудочной железы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pancreatic cancer</kwd><kwd>MRI</kwd><kwd>MRI assessment</kwd><kwd>tumor tissue</kwd><kwd>supposed pancreatic stump</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">финансирование за счет госзадания: регистрационный № 122032300207-0.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Состояние онкологической помощи населению России в 2021 году. Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022, 239 с.</mixed-citation><mixed-citation xml:lang="en">The state of oncological care to the population of Russia in 2021. Edited by A.D. Kaprin, V. V. Starinsky, A. O. Shakhzadova. Moscow: P. A. Herzen MNIOI – Branch of the National Medical Research Radiological Center, 2022, 239 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Tamburrino D, Partelli S, Crippa S, Manzoni A, Maurizi A, Falconi M. Selection criteria in resectable pancreatic cancer: a biological and morphological approach. World J Gastroenterol. 2014 Aug 28;20(32):11210–11215. https://doi.org/10.3748/wjg.v20.i32.11210</mixed-citation><mixed-citation xml:lang="en">Tamburrino D, Partelli S, Crippa S, Manzoni A, Maurizi A, Falconi M. Selection criteria in resectable pancreatic cancer: a biological and morphological approach. World J Gastroenterol. 2014 Aug 28;20(32):11210–11215. https://doi.org/10.3748/wjg.v20.i32.11210</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Schima W, Böhm G, Rösch CS, Klaus A, Függer R, Kopf H. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation. Cancer Imaging. 2020 Jul 23;20(1):52. https://doi.org/10.1186/s40644-020-00324-z</mixed-citation><mixed-citation xml:lang="en">Schima W, Böhm G, Rösch CS, Klaus A, Függer R, Kopf H. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation. Cancer Imaging. 2020 Jul 23;20(1):52. https://doi.org/10.1186/s40644-020-00324-z</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X, Lu N, Zhou Y, Xuan S, Zhang J, Giampieri F, et al. Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles. Int J Mol Sci. 2019 Jun 19;20(12):2988. https://doi.org/10.3390/ijms20122988</mixed-citation><mixed-citation xml:lang="en">Zhu X, Lu N, Zhou Y, Xuan S, Zhang J, Giampieri F, et al. Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles. Int J Mol Sci. 2019 Jun 19;20(12):2988. https://doi.org/10.3390/ijms20122988</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hijioka S, Hara K, Mizuno N, Imaoka H, Bhatia V, Mekky MA, et al. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol. 2016 Sep;51(9):923–930. https://doi.org/10.1007/s00535-016-1164-6</mixed-citation><mixed-citation xml:lang="en">Hijioka S, Hara K, Mizuno N, Imaoka H, Bhatia V, Mekky MA, et al. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol. 2016 Sep;51(9):923–930. https://doi.org/10.1007/s00535-016-1164-6</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson JM, Mukherjee S, Brunner TB, Partridge M, Hawkins MA. Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy. Clin Oncol (R Coll Radiol). 2017 Jun;29(6):370–377. https://doi.org/10.1016/j.clon.2017.01.038</mixed-citation><mixed-citation xml:lang="en">Wilson JM, Mukherjee S, Brunner TB, Partridge M, Hawkins MA. Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy. Clin Oncol (R Coll Radiol). 2017 Jun;29(6):370–377. https://doi.org/10.1016/j.clon.2017.01.038</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bieliuniene E, Frøkjær JB, Pockevicius A, Kemesiene J, Lukosevicius S, Basevicius A, et al. Magnetic Resonance Imaging as a Valid Noninvasive Tool for the Assessment of Pancreatic Fibrosis. Pancreas. 2019 Jan;48(1):85–93. https://doi.org/10.1097/MPA.0000000000001206</mixed-citation><mixed-citation xml:lang="en">Bieliuniene E, Frøkjær JB, Pockevicius A, Kemesiene J, Lukosevicius S, Basevicius A, et al. Magnetic Resonance Imaging as a Valid Noninvasive Tool for the Assessment of Pancreatic Fibrosis. Pancreas. 2019 Jan;48(1):85–93. https://doi.org/10.1097/MPA.0000000000001206</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Байчоров М. Э. Предупреждение осложнений после лапароскопической панкреатодуоденальной резекции: Дисс. … докт. мед. наук. М., 2021, 26 с.</mixed-citation><mixed-citation xml:lang="en">Baichorov ME. Prevention of complications after laparoscopic pancreatoduodenal resection. Dissertation. Moscow, 2021. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Горин Д. С., Кригер А. Г., Галкин Г. В., Калинин Д. В., Глотов А. В., Калдаров А. Р. и др. Прогнозирование возникновения панкреатического свища после панкреатодуоденальной резекции. Хирургия. Журнал им. Н. И. Пирогова. 2020;(7):61–67. https://doi.org/10.17116/hirurgia202007161, EDN: OURZWR</mixed-citation><mixed-citation xml:lang="en">Gorin DS, Kriger AG, Galkin GV, Kalinin DV, Glotov AV, Kaldarov AR, et al. Predicting of pancreatic fistula after pancreatoduodenectomy. Pirogov Russian Journal of Surgery. 2020;(7):61–67. (In Russ.). https://doi.org/10.17116/hirurgia202007161, EDN: OURZWR</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Коваленко З. А., Ефанов М. Г. Шкалы прогноза панкреатической фистулы после операции Уиппла. Аналитический обзор литературы. Хирургия. Журнал им. Н. И. Пирогова. 2021;(7):71–76. https://doi.org/10.17116/hirurgia202107171, EDN: ZRAZZQ</mixed-citation><mixed-citation xml:lang="en">Kovalenko ZA, Efanov MG. Scoring systems to predict pancreatic fistula after Whipple procedure. Pirogov Russian Journal of Surgery. 2021;(7):71–76. (In Russ.). https://doi.org/10.17116/hirurgia202107171, EDN: ZRAZZQ</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013 Jan;216(1):1–14. https://doi.org/10.1016/j.jamcollsurg.2012.09.002</mixed-citation><mixed-citation xml:lang="en">Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013 Jan;216(1):1–14. https://doi.org/10.1016/j.jamcollsurg.2012.09.002</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP, et al. A multi-institutional external validation of the fistula risk score for pancreatoduodenectomy. J Gastrointest Surg. 2014 Jan;18(1):172–179. https://doi.org/10.1007/s11605-013-2337-8</mixed-citation><mixed-citation xml:lang="en">Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP, et al. A multi-institutional external validation of the fistula risk score for pancreatoduodenectomy. J Gastrointest Surg. 2014 Jan;18(1):172–179. https://doi.org/10.1007/s11605-013-2337-8</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017 Mar;161(3):584–591. https://doi.org/10.1016/j.surg.2016.11.014</mixed-citation><mixed-citation xml:lang="en">Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017 Mar;161(3):584–591. https://doi.org/10.1016/j.surg.2016.11.014</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mungroop TH, van Rijssen LB, van Klaveren D, Smits FJ, van Woerden V, Linnemann RJ, et al. Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation. Ann Surg. 2019 May;269(5):937–943. https://doi.org/10.1097/SLA.0000000000002620</mixed-citation><mixed-citation xml:lang="en">Mungroop TH, van Rijssen LB, van Klaveren D, Smits FJ, van Woerden V, Linnemann RJ, et al. Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation. Ann Surg. 2019 May;269(5):937–943. https://doi.org/10.1097/SLA.0000000000002620</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Горин Д. С. Специфические осложнения в хирургии опухолей поджелудочной железы: Дисс. … докт. мед. наук. М., 2022.</mixed-citation><mixed-citation xml:lang="en">Gorin DS. Specific complications in surgery of pancreatic tumors. Dissertation. Moscow. Moscow, 2022. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sawlani V, Patel MD, Davies N, Flintham R, Wesolowski R, Ughratdar I, et al. Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesions. Insights Imaging. 2020 Jul 17;11(1):84. https://doi.org/10.1186/s13244-020-00888-1</mixed-citation><mixed-citation xml:lang="en">Sawlani V, Patel MD, Davies N, Flintham R, Wesolowski R, Ughratdar I, et al. Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesions. Insights Imaging. 2020 Jul 17;11(1):84. https://doi.org/10.1186/s13244-020-00888-1</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kantor O, Talamonti MS, Pitt HA, Vollmer CM, Riall TS, Hall BL, et al. Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy. J Am Coll Surg. 2017 May;224(5):816–825. https://doi.org/10.1016/j.jamcollsurg.2017.01.054</mixed-citation><mixed-citation xml:lang="en">Kantor O, Talamonti MS, Pitt HA, Vollmer CM, Riall TS, Hall BL, et al. Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy. J Am Coll Surg. 2017 May;224(5):816–825. https://doi.org/10.1016/j.jamcollsurg.2017.01.054</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
